Evidence map›Paper›PMID 12023942›Full record

ArticleBritish journal of pharmacology2002

Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness.

Herman Meurs, Sue McKay, Harm Maarsingh, Marco A M Hamer, Lejla Macic, Niek Molendijk, Johan Zaagsma

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 145 citations in OpenAlex.

  1. Regulatory haplotypes in ARG1 are associated with altered bronchodilator response.American journal of respiratory and critical care medicine · 2011
    Trial
  2. M-MDSCFrontiers in immunology · 2023
    Article
  3. Review
  4. An update on the diagnostic biomarkers for asthma.Journal of family medicine and primary care · 2021
    Review
  5. Arginine Therapy for Lung Diseases.Frontiers in pharmacology · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. GC/MS-Based Metabolomics Reveals Biomarkers in Asthma Murine Model Modulated byEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Novel therapeutic strategies for adult obese asthmatics.Immunology and allergy clinics of North America · 2014
    Review
  14. Arginase I levels are decreased in the plasma of pediatric patients with atopic dermatitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2014
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Herman MeursDepartment of Molecular Pharmacology, University Centre for Pharmacy, Antonius Deusinglaan 1, Groningen, NL-9713 AV, The Netherlands. h.meurs@farm.rug.nl
Sue McKay
Harm Maarsingh
Marco A M Hamer
Lejla Macic
Niek Molendijk
Johan Zaagsma
University of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. A deficiency of constitutive nitric oxide synthase (cNOS)-derived nitric oxide (NO), due to reduced availability of L-arginine, importantly contributes to allergen-induced airway hyperresponsiveness (AHR) after the early asthmatic reaction (EAR). Since cNOS and arginase use L-arginine as a common substrate, we hypothesized that increased arginase activity is involved in the allergen-induced NO deficiency and AHR. 2. Using a guinea-pig model of allergic asthma, we addressed this hypothesis by examining the effects of the specific arginase inhibitor N(omega)-hydroxy-nor-L-arginine (nor-NOHA) on the responsiveness to methacholine of isolated perfused tracheae from unchallenged control animals and from animals 6 h after ovalbumin challenge. Arginase activity in these preparations was investigated by measuring the conversion of L-[14C]arginine to [14C]urea. 3. Airways from allergen-challenged animals showed a 2 fold (P<0.001) increase in responsiveness to intraluminal (IL) administration of methacholine compared to controls. A similar hyperresponsiveness (1.8 fold, P<0.01) was observed in control airways incubated with the NOS inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME, 0.1 mM, IL), while L-NAME had no further effect on the airways from challenged animals. 4. Remarkably, 5 microM nor-NOHA (IL) normalized the hyperresponsiveness of challenged airways to basal control (P<0.001), and this effect was fully reversed again by 0.1 mM L-NAME (P<0.05). Moreover, arginase activity in homogenates of the hyperresponsive airways was 3.5 fold (P<0.001) enhanced compared to controls. 5. The results indicate that enhanced arginase activity contributes to allergen-induced deficiency of cNOS-derived NO and AHR after the EAR, presumably by competition with cNOS for the common substrate, L-arginine. This is the first demonstration that arginase is involved in the pathophysiology of asthma.

Indexed as

AllergensAnimalsArginaseArginineBronchial HyperreactivityBronchoconstrictor AgentsEnzyme InhibitorsGuinea PigsIn Vitro TechniquesMethacholine ChlorideModels, AnimalNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide SynthaseOvalbuminTracheaAllergensArginaseArginineBronchoconstrictor AgentsEnzyme InhibitorsMethacholine ChlorideNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide SynthaseN(omega)-hydroxynorarginineOvalbumin

Identifiers

PMID12023942
PMCPMC1573363
OpenAlexW2142530497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.